Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

disease progression

The great schism

Technological advances in our industry are about to exacerbate societal inequality

- PMLiVE

Pushing the accelerator

How eClinical technologies can speed  up the drug development process

Breathing data

Novartis’ new CEO-designate points to an evolutionary leap

- PMLiVE

Merck earmarks €35m for Italian biologics site development

Pharma firm plans new biotech production line at its Bari facility

- PMLiVE

Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio

Germany and the UK will be the first to receive the skin cancer treatment

Why AI might be the rep’s best friend

When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...

Anthill Agency

- PMLiVE

Merck mulls sale of consumer health division

The German pharma group will focus on its science and technology businesses

- PMLiVE

NICE expands Merck KGaA’s Erbitux reach

Backs the medicines use for patients with SCCHN

Roche Basel Switzerland

Ocrevus off to a flying start as Roche raises 2017 forecasts

New multiple sclerosis drug posts positive results in first quarter

- PMLiVE

CHMP backs three immuno-oncology drugs for solid tumours

Roche, MSD and Merck/Pfizer are all on course for new European approvals later this year

- PMLiVE

Merck gets CHMP backing for long-delayed oral MS drug

Cladribine, which will be branded as Mavenclad, was originally rejected by the committee in 2010

- PMLiVE

Smart solutions

How technology could help pharma breathe new life into branded respiratory drugs

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links